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PreviewsDivide and Conquer:
Division of Labor by B-1 B Cells
Capsular polysaccharides enhance bacterial viru-
lence. In this issue of Immunity, Haas et al. (2005)
demonstrate a division of labor between the B-1 B cell
subsets: natural antibodies from B-1a cells limit in-
fection by Streptococcus pneumoniae, whereas B-1b
cells generate the anticapsule-induced response that
prevents fatal infection.
Pathogens employ a variety of strategies to overcome
host immune surveillance. Clinically important bacteria
such as Streptococcus pneumoniae, Haemophilus in-
fluenzae, and Neisseria meningitidis express polysaccha-
ride (PS) capsules. These PS capsules are T cell-inde-
pendent type-2 (TI-2) antigens, have limited intrinsic
immunogenicity, and can also mask immunogenic sur-
face molecules, thus enabling persistence of these
pathogens in the host. A critical factor in preventing
systemic infection is the ability of B cells to rapidly gen-
erate protective antibodies against capsular PS. Pneu-
mococcal PS can elicit protective immunity, but vac-
cine development is complicated by the existence of
more than 90 serotypes and their geographical distribu-
tion. The PS vaccine against S. pneumoniae contains
23 prevalent PS serotypes including the PS3 used in
Haas et al. (2005). This PS vaccine generates effective
antibody responses in adults but not in children. The
lack of vaccine anti-PS response in the children under
the age of 2 years can be overcome by the covalent
conjugation of PS (from a subset of serotypes) to a pro-
tein carrier to elicit T cell-dependent responses (Peltola
et al., 2004). Despite this progress, it is still important
to understand the mechanisms underlying children’s
hypersusceptibilty to pneumococcal infection. The work
from Haas et al. (2005) identified the B cell subsets and
humoral immune mechanisms responsible for anti-PS
antibody responses using a mouse model.
Murine mature B cells are heterogeneous and belong
to four subsets: follicular (FO), marginal zone (MZ), B-1a
(CD5+), and B-1b (CD5−). FO B cells recirculate in blood
and among the lymphoid follicles and mount antibody
responses against T cell-dependent protein antigens
(reviewed in [Martin and Kearney, 2001]). Both MZ B
cells, localized proximal to the marginal sinus of the
spleen, and B-1 cells, most abundant in peritoneal and
pleural cavities, generate T cell-independent responses.
B-1a cells are the major source of natural antibodies
that occur spontaneously in naive, “antigen-free” mice,
and natural antibodies are important in controlling
pathogenic viruses and bacteria including S. pneumo-
niae (reviewed in [Baumgarth et al., 2005]). However, a
specific role for B-1b cells, generating immunity to the
relapsing fever bacterium Borrelia hermsii, was only re-
cently found (Alugupalli et al., 2004).
In this issue of Immunity, Haas et al. (2005) utilize
the well-established murine model of S. pneumoniaeinfection to compare mice sufficient, deficient, or over-
expressing CD19: conveniently, they establish that
CD19−/− mice have an intact B-1b population and a se-
vere deficiency in B-1a and MZ cells, yet mice overex-
pressing human CD19 (hCD19) have B-1a cells but
have severely reduced B-1b cells. Surprisingly, they
find CD19 is not required for generating protective IgM
or IgG3 responses against the PS of S. pneumoniae.
This observation, and analyses of B cell populations in
the CD19−/− or hCD19 mice, indicate that B-1b cells
make the protective anti-PS response. By adoptive
transfer of purified B cell subsets into immunodeficient
(rag−/−) mice, Haas et al. (2005) demonstrate that B-1b
cells but not B-1a cells generate the IgM and IgG3 re-
sponse essential and sufficient to prevent lethal infec-
tion by S. pneumoniae. However, B-1a cells have an
important role: naive hCD19 mice survive when chal-
lenged with a sublethal dose of S. pneumoniae, S. pneu-
moniae natural antibodies are intact in hCD19 mice and
transferred serum from wild-type mice confers protec-
tion of CD19−/− mice. Importantly, transferred B-1a cells
spontaneously produce low levels of PS-reactive IgM
(but not IgG3) antibody. Therefore, to combat S. pneu-
moniae, B-1 subsets collaborate: B-1a cells secrete
natural antibody that protects against infection or
lowers bacterial burden if infection is established, whereas
B-1b cells secrete the induced antibody needed to
clear bacteria and permit survival.
The molecular rules for this division of labor are as
yet undefined. Although CD5 expression is the pheno-
typic criterion used to distinguish B-1a from B-1b sub-
sets, several biological distinctions exist. Defects in
BCR signaling more profoundly affect B-1a cell devel-
opment (Hardy and Hayakawa, 2001). The Haas et al.
(2005) paper builds on prior evidence that CD19 ex-
pression is essential for the development of B-1a but
not B-1b cells. xid mice (defective in BCR signaling due
to a mutation in Bruton’s tyrosine kinase) have defects
in both B-1a and B-1b cells, although introduction of IL-9
as a transgene rescues B-1b but not B-1a development
(Knoops et al., 2004). The Ig repertoires of B-1a versus
B-1b are also distinct. Interestingly, single-cell unbi-
ased samples reveal that B-1a cells have fewer N re-
gion additions at VH-D and D-JH Ig gene junctions than
B-1b cells (Kantor et al., 1997). This distinction between
N region frequencies is consistent with findings that
bone marrow progenitors express Tdt, the enzyme re-
sponsible for N regions, and have progenitor activity for
B-1b but not B-1a cells. By adoptive transfer, we found
bone marrow sufficient for the generation of B-1b cells
capable of eradicating B. hermsii (Alugupalli et al.,
2004). Therefore, different Ig repertoires, requirements
for signals to supplement BCR signaling or as yet unap-
preciated intrinsic differences could each contribute to
the unique competency of B-1b cells to mount the pro-
tective anti-PS response.
The generation of B cell memory has been regarded
as exclusively T cell dependent. We recently found that
B-1b cells generate long-lasting IgM memory in T cell-
deficient mice infected with B. hermsii. The present pa-
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